The Market Reports

Index

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Artemisinin Combination Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Artemether+Lumefantrine

1.2.3 Artesunate+Amodiaquine

1.2.4 Dihydroartemisinin+Piperaquine

1.2.5 Artesunate+Mefloquine

1.2.6 Artesunate+Sulfadoxine-Pyrimethamine

1.2.7 Pyronaridine-Artesunate

1.2.8 Other

1.3 Market by Application

1.3.1 Global Artemisinin Combination Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Artemisinin Combination Therapy Market Perspective (2019-2030)

2.2 Artemisinin Combination Therapy Growth Trends by Region

2.2.1 Global Artemisinin Combination Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Artemisinin Combination Therapy Historic Market Size by Region (2019-2024)

2.2.3 Artemisinin Combination Therapy Forecasted Market Size by Region (2025-2030)

2.3 Artemisinin Combination Therapy Market Dynamics

2.3.1 Artemisinin Combination Therapy Industry Trends

2.3.2 Artemisinin Combination Therapy Market Drivers

2.3.3 Artemisinin Combination Therapy Market Challenges

2.3.4 Artemisinin Combination Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Artemisinin Combination Therapy Players by Revenue

3.1.1 Global Top Artemisinin Combination Therapy Players by Revenue (2019-2024)

3.1.2 Global Artemisinin Combination Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Artemisinin Combination Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Artemisinin Combination Therapy Revenue

3.4 Global Artemisinin Combination Therapy Market Concentration Ratio

3.4.1 Global Artemisinin Combination Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Artemisinin Combination Therapy Revenue in 2023

3.5 Artemisinin Combination Therapy Key Players Head office and Area Served

3.6 Key Players Artemisinin Combination Therapy Product Solution and Service

3.7 Date of Enter into Artemisinin Combination Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Artemisinin Combination Therapy Breakdown Data by Type

4.1 Global Artemisinin Combination Therapy Historic Market Size by Type (2019-2024)

4.2 Global Artemisinin Combination Therapy Forecasted Market Size by Type (2025-2030)

5 Artemisinin Combination Therapy Breakdown Data by Application

5.1 Global Artemisinin Combination Therapy Historic Market Size by Application (2019-2024)

5.2 Global Artemisinin Combination Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Artemisinin Combination Therapy Market Size (2019-2030)

6.2 North America Artemisinin Combination Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Artemisinin Combination Therapy Market Size by Country (2019-2024)

6.4 North America Artemisinin Combination Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Artemisinin Combination Therapy Market Size (2019-2030)

7.2 Europe Artemisinin Combination Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Artemisinin Combination Therapy Market Size by Country (2019-2024)

7.4 Europe Artemisinin Combination Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Artemisinin Combination Therapy Market Size (2019-2030)

8.2 Asia-Pacific Artemisinin Combination Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Artemisinin Combination Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Artemisinin Combination Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Artemisinin Combination Therapy Market Size (2019-2030)

9.2 Latin America Artemisinin Combination Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Artemisinin Combination Therapy Market Size by Country (2019-2024)

9.4 Latin America Artemisinin Combination Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Artemisinin Combination Therapy Market Size (2019-2030)

10.2 Middle East & Africa Artemisinin Combination Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Artemisinin Combination Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Artemisinin Combination Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 KPC Pharmaceuticals

11.1.1 KPC Pharmaceuticals Company Detail

11.1.2 KPC Pharmaceuticals Business Overview

11.1.3 KPC Pharmaceuticals Artemisinin Combination Therapy Introduction

11.1.4 KPC Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2019-2024)

11.1.5 KPC Pharmaceuticals Recent Development

11.2 Shanghai Fosun Pharmaceutical Industrial Development

11.2.1 Shanghai Fosun Pharmaceutical Industrial Development Company Detail

11.2.2 Shanghai Fosun Pharmaceutical Industrial Development Business Overview

11.2.3 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Introduction

11.2.4 Shanghai Fosun Pharmaceutical Industrial Development Revenue in Artemisinin Combination Therapy Business (2019-2024)

11.2.5 Shanghai Fosun Pharmaceutical Industrial Development Recent Development

11.3 Sanofi

11.3.1 Sanofi Company Detail

11.3.2 Sanofi Business Overview

11.3.3 Sanofi Artemisinin Combination Therapy Introduction

11.3.4 Sanofi Revenue in Artemisinin Combination Therapy Business (2019-2024)

11.3.5 Sanofi Recent Development

11.4 Desano Holdings

11.4.1 Desano Holdings Company Detail

11.4.2 Desano Holdings Business Overview

11.4.3 Desano Holdings Artemisinin Combination Therapy Introduction

11.4.4 Desano Holdings Revenue in Artemisinin Combination Therapy Business (2019-2024)

11.4.5 Desano Holdings Recent Development

11.5 Calyx Chemicals and Pharmaceuticals

11.5.1 Calyx Chemicals and Pharmaceuticals Company Detail

11.5.2 Calyx Chemicals and Pharmaceuticals Business Overview

11.5.3 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Introduction

11.5.4 Calyx Chemicals and Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2019-2024)

11.5.5 Calyx Chemicals and Pharmaceuticals Recent Development

11.6 Mylan

11.6.1 Mylan Company Detail

11.6.2 Mylan Business Overview

11.6.3 Mylan Artemisinin Combination Therapy Introduction

11.6.4 Mylan Revenue in Artemisinin Combination Therapy Business (2019-2024)

11.6.5 Mylan Recent Development

11.7 Novartis

11.7.1 Novartis Company Detail

11.7.2 Novartis Business Overview

11.7.3 Novartis Artemisinin Combination Therapy Introduction

11.7.4 Novartis Revenue in Artemisinin Combination Therapy Business (2019-2024)

11.7.5 Novartis Recent Development

11.8 Denk Pharma

11.8.1 Denk Pharma Company Detail

11.8.2 Denk Pharma Business Overview

11.8.3 Denk Pharma Artemisinin Combination Therapy Introduction

11.8.4 Denk Pharma Revenue in Artemisinin Combination Therapy Business (2019-2024)

11.8.5 Denk Pharma Recent Development

11.9 Hovid Berhad

11.9.1 Hovid Berhad Company Detail

11.9.2 Hovid Berhad Business Overview

11.9.3 Hovid Berhad Artemisinin Combination Therapy Introduction

11.9.4 Hovid Berhad Revenue in Artemisinin Combination Therapy Business (2019-2024)

11.9.5 Hovid Berhad Recent Development

11.10 Ipca Laboratories

11.10.1 Ipca Laboratories Company Detail

11.10.2 Ipca Laboratories Business Overview

11.10.3 Ipca Laboratories Artemisinin Combination Therapy Introduction

11.10.4 Ipca Laboratories Revenue in Artemisinin Combination Therapy Business (2019-2024)

11.10.5 Ipca Laboratories Recent Development

11.11 Cipla

11.11.1 Cipla Company Detail

11.11.2 Cipla Business Overview

11.11.3 Cipla Artemisinin Combination Therapy Introduction

11.11.4 Cipla Revenue in Artemisinin Combination Therapy Business (2019-2024)

11.11.5 Cipla Recent Development

11.12 Aspen Pharmacare Holdings

11.12.1 Aspen Pharmacare Holdings Company Detail

11.12.2 Aspen Pharmacare Holdings Business Overview

11.12.3 Aspen Pharmacare Holdings Artemisinin Combination Therapy Introduction

11.12.4 Aspen Pharmacare Holdings Revenue in Artemisinin Combination Therapy Business (2019-2024)

11.12.5 Aspen Pharmacare Holdings Recent Development

11.13 Ajanta Pharma

11.13.1 Ajanta Pharma Company Detail

11.13.2 Ajanta Pharma Business Overview

11.13.3 Ajanta Pharma Artemisinin Combination Therapy Introduction

11.13.4 Ajanta Pharma Revenue in Artemisinin Combination Therapy Business (2019-2024)

11.13.5 Ajanta Pharma Recent Development

11.14 Guilin Pharmaceuticals

11.14.1 Guilin Pharmaceuticals Company Detail

11.14.2 Guilin Pharmaceuticals Business Overview

11.14.3 Guilin Pharmaceuticals Artemisinin Combination Therapy Introduction

11.14.4 Guilin Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2019-2024)

11.14.5 Guilin Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

List of Tables

Table 1. Global Artemisinin Combination Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Artemether+Lumefantrine

Table 3. Key Players of Artesunate+Amodiaquine

Table 4. Key Players of Dihydroartemisinin+Piperaquine

Table 5. Key Players of Artesunate+Mefloquine

Table 6. Key Players of Artesunate+Sulfadoxine-Pyrimethamine

Table 7. Key Players of Pyronaridine-Artesunate

Table 8. Key Players of Other

Table 9. Global Artemisinin Combination Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Artemisinin Combination Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 11. Global Artemisinin Combination Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 12. Global Artemisinin Combination Therapy Market Share by Region (2019-2024)

Table 13. Global Artemisinin Combination Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 14. Global Artemisinin Combination Therapy Market Share by Region (2025-2030)

Table 15. Artemisinin Combination Therapy Market Trends

Table 16. Artemisinin Combination Therapy Market Drivers

Table 17. Artemisinin Combination Therapy Market Challenges

Table 18. Artemisinin Combination Therapy Market Restraints

Table 19. Global Artemisinin Combination Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 20. Global Artemisinin Combination Therapy Market Share by Players (2019-2024)

Table 21. Global Top Artemisinin Combination Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artemisinin Combination Therapy as of 2023)

Table 22. Ranking of Global Top Artemisinin Combination Therapy Companies by Revenue (US$ Million) in 2023

Table 23. Global 5 Largest Players Market Share by Artemisinin Combination Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 24. Key Players Headquarters and Area Served

Table 25. Key Players Artemisinin Combination Therapy Product Solution and Service

Table 26. Date of Enter into Artemisinin Combination Therapy Market

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Artemisinin Combination Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 29. Global Artemisinin Combination Therapy Revenue Market Share by Type (2019-2024)

Table 30. Global Artemisinin Combination Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 31. Global Artemisinin Combination Therapy Revenue Market Share by Type (2025-2030)

Table 32. Global Artemisinin Combination Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 33. Global Artemisinin Combination Therapy Revenue Market Share by Application (2019-2024)

Table 34. Global Artemisinin Combination Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 35. Global Artemisinin Combination Therapy Revenue Market Share by Application (2025-2030)

Table 36. North America Artemisinin Combination Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Artemisinin Combination Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Artemisinin Combination Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Artemisinin Combination Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. Europe Artemisinin Combination Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 41. Europe Artemisinin Combination Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 42. Asia-Pacific Artemisinin Combination Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 43. Asia-Pacific Artemisinin Combination Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 44. Asia-Pacific Artemisinin Combination Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 45. Latin America Artemisinin Combination Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Latin America Artemisinin Combination Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 47. Latin America Artemisinin Combination Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 48. Middle East & Africa Artemisinin Combination Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 49. Middle East & Africa Artemisinin Combination Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 50. Middle East & Africa Artemisinin Combination Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 51. KPC Pharmaceuticals Company Detail

Table 52. KPC Pharmaceuticals Business Overview

Table 53. KPC Pharmaceuticals Artemisinin Combination Therapy Product

Table 54. KPC Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)

Table 55. KPC Pharmaceuticals Recent Development

Table 56. Shanghai Fosun Pharmaceutical Industrial Development Company Detail

Table 57. Shanghai Fosun Pharmaceutical Industrial Development Business Overview

Table 58. Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Product

Table 59. Shanghai Fosun Pharmaceutical Industrial Development Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)

Table 60. Shanghai Fosun Pharmaceutical Industrial Development Recent Development

Table 61. Sanofi Company Detail

Table 62. Sanofi Business Overview

Table 63. Sanofi Artemisinin Combination Therapy Product

Table 64. Sanofi Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)

Table 65. Sanofi Recent Development

Table 66. Desano Holdings Company Detail

Table 67. Desano Holdings Business Overview

Table 68. Desano Holdings Artemisinin Combination Therapy Product

Table 69. Desano Holdings Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)

Table 70. Desano Holdings Recent Development

Table 71. Calyx Chemicals and Pharmaceuticals Company Detail

Table 72. Calyx Chemicals and Pharmaceuticals Business Overview

Table 73. Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Product

Table 74. Calyx Chemicals and Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)

Table 75. Calyx Chemicals and Pharmaceuticals Recent Development

Table 76. Mylan Company Detail

Table 77. Mylan Business Overview

Table 78. Mylan Artemisinin Combination Therapy Product

Table 79. Mylan Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)

Table 80. Mylan Recent Development

Table 81. Novartis Company Detail

Table 82. Novartis Business Overview

Table 83. Novartis Artemisinin Combination Therapy Product

Table 84. Novartis Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)

Table 85. Novartis Recent Development

Table 86. Denk Pharma Company Detail

Table 87. Denk Pharma Business Overview

Table 88. Denk Pharma Artemisinin Combination Therapy Product

Table 89. Denk Pharma Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)

Table 90. Denk Pharma Recent Development

Table 91. Hovid Berhad Company Detail

Table 92. Hovid Berhad Business Overview

Table 93. Hovid Berhad Artemisinin Combination Therapy Product

Table 94. Hovid Berhad Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)

Table 95. Hovid Berhad Recent Development

Table 96. Ipca Laboratories Company Detail

Table 97. Ipca Laboratories Business Overview

Table 98. Ipca Laboratories Artemisinin Combination Therapy Product

Table 99. Ipca Laboratories Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)

Table 100. Ipca Laboratories Recent Development

Table 101. Cipla Company Detail

Table 102. Cipla Business Overview

Table 103. Cipla Artemisinin Combination Therapy Product

Table 104. Cipla Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)

Table 105. Cipla Recent Development

Table 106. Aspen Pharmacare Holdings Company Detail

Table 107. Aspen Pharmacare Holdings Business Overview

Table 108. Aspen Pharmacare Holdings Artemisinin Combination Therapy Product

Table 109. Aspen Pharmacare Holdings Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)

Table 110. Aspen Pharmacare Holdings Recent Development

Table 111. Ajanta Pharma Company Detail

Table 112. Ajanta Pharma Business Overview

Table 113. Ajanta Pharma Artemisinin Combination Therapy Product

Table 114. Ajanta Pharma Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)

Table 115. Ajanta Pharma Recent Development

Table 116. Guilin Pharmaceuticals Company Detail

Table 117. Guilin Pharmaceuticals Business Overview

Table 118. Guilin Pharmaceuticals Artemisinin Combination Therapy Product

Table 119. Guilin Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2019-2024) & (US$ Million)

Table 120. Guilin Pharmaceuticals Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Artemisinin Combination Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Artemisinin Combination Therapy Market Share by Type: 2023 VS 2030

Figure 3. Artemether+Lumefantrine Features

Figure 4. Artesunate+Amodiaquine Features

Figure 5. Dihydroartemisinin+Piperaquine Features

Figure 6. Artesunate+Mefloquine Features

Figure 7. Artesunate+Sulfadoxine-Pyrimethamine Features

Figure 8. Pyronaridine-Artesunate Features

Figure 9. Other Features

Figure 10. Global Artemisinin Combination Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 11. Global Artemisinin Combination Therapy Market Share by Application: 2023 VS 2030

Figure 12. Hospital Case Studies

Figure 13. Clinic Case Studies

Figure 14. Other Case Studies

Figure 15. Artemisinin Combination Therapy Report Years Considered

Figure 16. Global Artemisinin Combination Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 17. Global Artemisinin Combination Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Artemisinin Combination Therapy Market Share by Region: 2023 VS 2030

Figure 19. Global Artemisinin Combination Therapy Market Share by Players in 2023

Figure 20. Global Top Artemisinin Combination Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artemisinin Combination Therapy as of 2023)

Figure 21. The Top 10 and 5 Players Market Share by Artemisinin Combination Therapy Revenue in 2023

Figure 22. North America Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. North America Artemisinin Combination Therapy Market Share by Country (2019-2030)

Figure 24. United States Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Artemisinin Combination Therapy Market Share by Country (2019-2030)

Figure 28. Germany Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Asia-Pacific Artemisinin Combination Therapy Market Share by Region (2019-2030)

Figure 36. China Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Japan Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. South Korea Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Southeast Asia Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. India Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Australia Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Latin America Artemisinin Combination Therapy Market Share by Country (2019-2030)

Figure 44. Mexico Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Brazil Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Artemisinin Combination Therapy Market Share by Country (2019-2030)

Figure 48. Turkey Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Artemisinin Combination Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. KPC Pharmaceuticals Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)

Figure 51. Shanghai Fosun Pharmaceutical Industrial Development Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)

Figure 52. Sanofi Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)

Figure 53. Desano Holdings Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)

Figure 54. Calyx Chemicals and Pharmaceuticals Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)

Figure 55. Mylan Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)

Figure 56. Novartis Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)

Figure 57. Denk Pharma Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)

Figure 58. Hovid Berhad Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)

Figure 59. Ipca Laboratories Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)

Figure 60. Cipla Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)

Figure 61. Aspen Pharmacare Holdings Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)

Figure 62. Ajanta Pharma Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)

Figure 63. Guilin Pharmaceuticals Revenue Growth Rate in Artemisinin Combination Therapy Business (2019-2024)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed